SCHEMBL3568772

SCHEMBL3568772

CO/C=C1/C(=O)NC(=O)c2cc(Br)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.46
MAOB P27338 5/20 0.46
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
CDK2 P24941 1/20 0.45
HSP90AA1 P07900 2/20 0.42
PLK4 O00444 2/20 0.41
TDP2 O95551 1/20 0.41
TGM2 P21980 1/20 0.40
CES1 P23141 1/20 0.40
RET P07949 1/20 0.40
PPOX P50336 1/20 0.40
PIM1 P11309 2/20 0.39
PIM3 Q86V86 2/20 0.39
PIM2 Q9P1W9 2/20 0.39
PLK1 P53350 1/20 0.39
CCNB2 O95067 2/20 0.39
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCNB3 Q8WWL7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3568777 1.00 MAOA (0.46) MAOAMAOBCDK4CCND1CDK2
SCHEMBL3574640 0.94 CDK4 (0.50) MAOAMAOBCDK4CCND1CDK2
SCHEMBL3563335 0.94 CDK4 (0.50) MAOAMAOBCDK4CCND1CDK2
SCHEMBL3563332 0.94 CDK4 (0.50) MAOAMAOBCDK4CCND1CDK2
SCHEMBL3562481 0.78 GSK3B (0.56) CDK2TGM2
SCHEMBL3562479 0.78 GSK3B (0.56) CDK2TGM2
SCHEMBL383829 0.77 MAOA (0.63) MAOAMAOBTDP2TGM2CES1
SCHEMBL3566976 0.77 GSK3B (0.49) CDK4CCND1CDK2PLK4RET
SCHEMBL3566975 0.77 GSK3B (0.49) CDK4CCND1CDK2PLK4RET
SCHEMBL3571389 0.76 PPOX (0.62) MAOAMAOBTGM2CES1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 MAOA 3210/4885MAOB 3131/4885CDK4 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.